Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Jun. 28, 2020	Jun. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings	$ 9,422	$ 9,356
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property and intangibles	3,473	3,466
Stock based compensation	589	572
Asset write-downs	33	989
Contingent consideration reversal	(983)	0
Net gain on sale of assets/businesses	(60)	(2,079)
Deferred tax provision	(428)	(694)
Credit losses and accounts receivable allowances	117	1
Changes in assets and liabilities, net of effects from acquisitions and divestitures:
Increase in accounts receivable	(520)	(336)
Increase in inventories	(637)	(423)
Decrease in accounts payable and accrued liabilities	(2,319)	(444)
Increase in other current and non-current assets	(1,048)	(862)
Decrease in other current and non-current liabilities	(829)	(55)
NET CASH FLOWS FROM OPERATING ACTIVITIES	6,810	9,491
CASH FLOWS FROM INVESTING ACTIVITIES
Additions to property, plant and equipment	(1,287)	(1,493)
Proceeds from the disposal of assets/businesses, net	87	3,018
Acquisitions, net of cash acquired	(949)	(5,346)
Purchases of investments	(8,551)	(1,517)
Sales of investments	2,417	2,132
Proceeds from credit support agreements, net	672	0
Other (primarily licenses and milestones)	(492)	1
NET CASH USED BY INVESTING ACTIVITIES	(8,103)	(3,205)
CASH FLOWS FROM FINANCING ACTIVITIES
Dividends to shareholders	(5,164)	(4,918)
Repurchase of common stock	(2,417)	(4,692)
Proceeds from short-term debt	2,717	15
Repayment of short-term debt	(17)	(12)
Proceeds from long-term debt, net of issuance costs	1	1
Repayment of long-term debt	(11)	(1,005)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net	708	463
Other	(489)	98
NET CASH USED BY FINANCING ACTIVITIES	(4,672)	(10,050)
Effect of exchange rate changes on cash and cash equivalents	(166)	33
Decrease in cash and cash equivalents	(6,131)	(3,731)
Cash and Cash equivalents, beginning of period	17,305	18,107
Cash and Cash equivalents, end of period	11,174	14,376
Acquisitions
Fair value of assets acquired	1,173	6,744
Fair value of liabilities assumed and noncontrolling interests	(224)	(1,398)
Net cash paid for acquisitions	949	$ 5,346
Auris Health
Adjustments to reconcile net earnings to cash flows from operating activities:
Contingent consideration reversal	$ (983)